MedPath
HSA Approval

CHLORNAMOL SUSPENSION

SIN03141P

CHLORNAMOL SUSPENSION

CHLORNAMOL SUSPENSION

June 8, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

N02BE51

paracetamol, combinations excl. psycholeptics

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

PARACETAMOL

250 mg/5 ml

Acetaminophen

CHLORPHENIRAMINE MALEATE

2 mg/5 ml

Chlorpheniramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CHLORNAMOL SUSPENSION - HSA Approval | MedPath